Celyad Oncology SA
Biotechnology
Healthcare
CYAD
14.26 M shares
NASDAQ US
traded
10 Feb 2023
listed
yes
open
1.45
52 week high
5.00
high
1.45
52 week low
1.32
previous Close
1.36
P/E ratio
market cap
89.92 M
div yield
0
net incoming
-6.15 M
29.28 %
net profit margin
-615300000.00 %
0.00 %
operating incoming
-6.36 M
2.96 %
net change in cash
0.00 %
cash on hand
12.02 M
-0.96 %
top